1. Home
  2. HCC vs MTSR Comparison

HCC vs MTSR Comparison

Compare HCC & MTSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCC
  • MTSR
  • Stock Information
  • Founded
  • HCC 2015
  • MTSR 2022
  • Country
  • HCC United States
  • MTSR United States
  • Employees
  • HCC N/A
  • MTSR N/A
  • Industry
  • HCC Coal Mining
  • MTSR
  • Sector
  • HCC Energy
  • MTSR
  • Exchange
  • HCC Nasdaq
  • MTSR NYSE
  • Market Cap
  • HCC 2.5B
  • MTSR 3.0B
  • IPO Year
  • HCC 2017
  • MTSR 2025
  • Fundamental
  • Price
  • HCC $43.63
  • MTSR $29.60
  • Analyst Decision
  • HCC Strong Buy
  • MTSR Strong Buy
  • Analyst Count
  • HCC 5
  • MTSR 6
  • Target Price
  • HCC $70.25
  • MTSR $55.25
  • AVG Volume (30 Days)
  • HCC 825.1K
  • MTSR 1.0M
  • Earning Date
  • HCC 07-31-2025
  • MTSR 05-12-2025
  • Dividend Yield
  • HCC 0.74%
  • MTSR N/A
  • EPS Growth
  • HCC N/A
  • MTSR N/A
  • EPS
  • HCC 2.01
  • MTSR N/A
  • Revenue
  • HCC $1,319,451,000.00
  • MTSR N/A
  • Revenue This Year
  • HCC N/A
  • MTSR N/A
  • Revenue Next Year
  • HCC $33.59
  • MTSR N/A
  • P/E Ratio
  • HCC $21.52
  • MTSR N/A
  • Revenue Growth
  • HCC N/A
  • MTSR N/A
  • 52 Week Low
  • HCC $38.00
  • MTSR $12.30
  • 52 Week High
  • HCC $75.53
  • MTSR $37.99
  • Technical
  • Relative Strength Index (RSI)
  • HCC 46.77
  • MTSR N/A
  • Support Level
  • HCC $45.77
  • MTSR N/A
  • Resistance Level
  • HCC $47.97
  • MTSR N/A
  • Average True Range (ATR)
  • HCC 1.76
  • MTSR 0.00
  • MACD
  • HCC -0.03
  • MTSR 0.00
  • Stochastic Oscillator
  • HCC 51.33
  • MTSR 0.00

About HCC Warrior Met Coal Inc.

Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.

About MTSR METSERA INC

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.

Share on Social Networks: